Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- Piramal Pharma Solutions y NP2 completan la fase de desarrollo de ciclofosfamida el próximo mesPiramal Pharma Solutions ("PPS"), una organización líder mundial de desarrollo y fabricación por contrato (CDMO) y parte de Piramal Pharma Ltd....
- Global Flexible Electrical Heating Elements Market Size, Share, Trends, and Forecast 2026-2031 | EV, Medical, and Aerospace Demand Drives up to 10.5% CAGRTarget EV batteries, medical devices and aerospace with customized, integrated heaters that boost efficiency, reliability and thermal control in compact, demanding applications.
- Global Seamless Metal Pipes Market Size, Share, Trends, and Forecast 2021-2031 | Hydrogen, Aerospace, and Infrastructure Investment Unlock 4%-6% CAGR OpportunitiesTarget high-margin alloy and stainless pipes for hydrogen, aerospace, pharma and water upgrades; localize supply to capture reshoring demand and reduce raw-material risk.
- Ensera launches alliance network with SHL Medical, Stevanato Group, Ypsomed, Argonaut and American InjectablesEnsera, a global CDMO specializing in commercialization support for injectable drug programs, has launched the Ensera Alliance Network, bringing together leading device platform and fill-finish specialists to address the complexity of commercializing...
- Zealand Pharma announces Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2 diabetesCompanies: Boehringer IngelheimCompany announcement – No. 52 / 2026
- Die 94. CMEF, die weltweit führende Fachmesse der Medizintechnikbranche, findet vom 21. bis 24. Oktober in Peking statt.PEKING, 1. Oktober 2026 -- Die 94. China International Medical Equipment Fair (CMEF) und die begleitenden Veranstaltungen – darunter die ICMD zum Thema Design und Herstellung medizinischer Geräte, die CRS mit Schwerpunkt auf Rehabilitation und assistiver Technologie, die...
- Mironid successfully doses initial cohorts in Phase 1 clinical trial investigating the Company’s first-in-class LoAc® small molecule for patients with ADPKDMironid successfully doses initial cohorts in Phase 1 clinical trial investigating the Company’s first-in-class LoAc® small molecule for patients with ADPKD
- Fresenius completa la adquisición de mAbxience, creando una plataforma más sólida para la futura expansión de su cartera de productosCompanies: Fresenius SE & Co. KGaAmAbxience ha anunciado hoy que Fresenius SE & Co. KGaA ha adquirido el 45% restante de mAbxience a Insud Pharma, consolidando así la exitosa...
- mAbxienceFresenius completes acquisition of mAbxience, creating a stronger platform for future portfolio expansionCompanies: Fresenius SE & Co. KGaAThe transaction builds on the successful partnership between Fresenius and mAbxience established in 2022. Full ownership creates a stronger platform to enhance quality and supply resilience, while supporting future innovation and broader patient access to high-quality biosimilars....
- Emerald Clinical Trials Appoints Michael Stibilj as Chief Executive Officer to Lead Next Phase of Global GrowthEmerald Clinical Trials, a leading global clinical research organization anchored in Asia-Pacific, today announced the appointment of Michael Stibilj as Chief Executive Officer, effective 1 October 2026. The appointment marks the beginning of the...
- The Rosen Law Firm PAROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMSWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hims & Hers Health, Inc. (NYSE: HIMS) between August 4, 2025 and July 29, 2026, both dates inclusive (the "Class Period"), of the important November 2, 2026 lead plaintiff deadline.SO WHAT: If you purchased Hims securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a...
- MediaplanetMediaplanet Announces the launch of The Future of Healthy Living campaign today!Mediaplanet today announces the launch of its Future of Healthy Living Campaign, a comprehensive health-awareness initiative publishing today within USA TODAY and online through the campaign's digital content hub, futureofpersonalhealth.com. The...